RASGRP1 has a dual regulatory role in tumor growth and the acute inflammatory response, and TNBC patients with higher expression of RASGRP1 have a better clinical prognosis [58,59], which was also confirmed in our study. The gene discussed is RASGRP1; the disease is neoplasm.